|Articles|June 1, 2004

Tabloid - Future Goals, Targets, and Treatments of Dyslipidemia
Volume 10
Issue 1 Treat

CME/CE Quiz

Download PDF: CME/CE Quiz

Articles in this issue

about 22 years ago

Article

Blocking intestinal cholesterol absorption for optimal lipid lowering

about 22 years ago

Article

Dual pathway inhibition: Attacking cholesterol on two fronts

about 22 years ago

Article

Beyond ATP III - Impact of recent clinical trials on future lipid management guidelines and therapeutic goals

about 22 years ago

Article

Future Goals, Targets, and Treatments of Dyslipidemia

about 22 years ago

Article

Aggressive lipid lowering superior to usual care in a real-world setting: The ALLIANCE study

about 22 years ago

Article

Managed Care Commentary:MCOs face new challenges

about 22 years ago

Article

Dual inhibition effective and safe in clinical practice: The EASE study

about 22 years ago

Article

Phytosterols may play role in atherosclerosis

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

CME/CE Quiz

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia

Cardiology Prices Vary Widely by Insurer and State

Hepatitis Prevention Programs Improve Liver Outcomes, but Gaps in Screening, Care Remain

Medicaid MFN Pricing Could Save $8.6 Billion